| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/000992289203100507 Low-Dose DDAVP in Nocturnal EnuresisSection of Urology Department of Surgery University of Michigan Medical Center Ann Arbor, Michigan
Section of Urology Department of Surgery University of Michigan Medical Center Ann Arbor, Michigan
Section of Urology Department of Surgery University of Michigan Medical Center Ann Arbor, Michigan A five-year experience with the vasopressin analogue desmopressin acetate (DDAVP) for nocturnal enuresis is described in 59 children. The initial starting dose of 5 µg at bedtime is lower than that reported in other series. Eighty-one percent of patients required 10 µg or less to achieve improvement or resolution of bedwetting.
This article has been cited by other articles:
|
||||||||||||
